Sweden· SE-20161106000012
OXERVATE 20 mikrogram/ml Ögondroppar, lösning
A medicinal product containing cenegermin, registered in Sweden by Dompé Farmaceutici S.p.A..
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Cenegermin
- Manufacturer
- Dompé Farmaceutici S.p.A.
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20161106000012
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cenegermin in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesOXERVATEDompé farmaceutici S.p.A.
- CzechiaOXERVATEDompé farmaceutici S.p.A., Milano
- FinlandOXERVATEDompé Farmaceutici S.p.A
- BelgiumOxervate 20 µg/mlDompé Farmaceutici
- NetherlandsOxervate 20 microgram/ml, oogdruppels, oplossingDompe Farmaceutici S.p.A.
- PolandOxervateDompé farmaceutici S.p.A.
- United KingdomOxervate 20micrograms/ml eye drops 1ml unit doseChapper Healthcare
- SpainOXERVATE 20 MICROGRAMOS/ML COLIRIO EN SOLUCIONDompe Farmaceutici S.P.A.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Oxervate
- Liechtenstein · Oxervate
- Norway · Oxervate
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3fd9e8a3-85ce-4a02-af6a-c76fe3b7d883 GET /v1/drugs/3fd9e8a3-85ce-4a02-af6a-c76fe3b7d883?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EMA",
"EPAR"
],
"se_npl_id": "20161106000012",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20161106000012",
"product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/oxervate"
}See everything about cenegermin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.